Biochem/physiol Actions
Primary TargetCPT1
General description
A cell-permeable, irreversible, and stereospecific compound that is shown to inhibit carnitine palmitoyltransferase (CPT)-1 and DGAT activity in the mitochondria of rat heart H9c2 myoblastic cells at a concentration of 1-80 µM and 40 µM, respectively.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Xu, F.Y., et al. 2003. J. Lipid Res.44, 415.
Packaging
Packaged under inert gas
2 mg in Glass bottle
Physical form
A 50 mM (2 mg/118 µL) solution of Etomoxir (Cat. No. 236020) in H2O.
Reconstitution
Following initial thaw, aliquot and freeze (-70°C). Aliquots are stable for up to 6 months at -70°C.
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: